Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05673798

Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

Conditions: Small Cell Lung Cancer

Sex: All
Enrollment: 569
Sponsor: The Second Hospital of Shandong University

Summary

In this retrospective study, patients diagnosed with SCLC between January 2011 to September 2022 were identified from database of the Second Hospital of Shandong University. Following inclusion criteria should be met: (1) Had histologically or cytologically confirmed newly diagnosed SCLC; (2) No cancer treatment has been done before; (3) Complete clinical, laboratory, imaging, treatment data and follow-up information. The exclusion criteria included: Patients without complete records for pathological information, complete epidemiology and other key clinical information.

Eligibility Criteria

Inclusion Criteria:Newly diagnosis of small cell lung cancerNo cancer treatment has been done beforeComplete clinical, laboratory, imaging, treatment data and follow-up informationExclusion Criteria:1. Without complete records for pathological information, complete epidemiology and other key clinical information

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05673798). StuddyBuddy aggregates publicly available trial information.